| 11.10.2021 07:41 | IPO | Transaction in Own Shares | RNS |
| 08.10.2021 07:00 | IPO | Share buyback programme | RNS |
| 06.10.2021 07:00 | IPO | Board changes | RNS |
| 05.10.2021 16:44 | IPO, TRX | Holding(s) in Company | RNS |
| 30.09.2021 16:11 | IPO | Total Voting Rights | RNS |
| 30.09.2021 07:45 | ONT, IPO | IP Group generates £84m from Oxford Nanopore IPO | RNS |
| 27.09.2021 12:40 | IPO | Director/PDMR Shareholding | RNS |
| 23.09.2021 15:57 | IPO | Further re Scrip Dividend | RNS |
| 16.09.2021 07:08 | IPO | Oxford Nanopore confirms ITF; MoU with Oracle | RNS |
| 10.09.2021 17:21 | IPO | Holding(s) in Company | RNS |
| 08.09.2021 10:53 | IPO | Director/PDMR Shareholding, SAYE scheme | RNS |
| 19.08.2021 10:41 | IPO | Scrip Dividend Reference Price | RNS |
| 12.08.2021 17:05 | IPO | Director Declaration | RNS |
| 05.08.2021 07:00 | IPO | Half-yearly results | RNS |
| 27.07.2021 07:03 | IPO | Portfolio company Artios Pharma raises $153m | Reach |
| 22.07.2021 11:30 | IPO | Notice of Results | RNS |
| 01.07.2021 07:00 | IPO | Total Voting Rights | RNS |
| 28.06.2021 07:30 | IPO | Director/PDMR Shareholding | RNS |
| 18.06.2021 09:52 | IPO | Director/PDMR Shareholding | RNS |
| 17.06.2021 07:00 | IPO | Portfolio company Apollo Therapeutics raises $145m | Reach |
| 15.06.2021 08:00 | IPO | Further re Scrip Dividend | RNS |
| 09.06.2021 11:29 | IPO | Result of AGM | RNS |
| 09.06.2021 07:00 | IPO | AGM Statement | RNS |
| 07.06.2021 07:00 | IPO | Portfolio co Iksuda completes $42m financing round | Reach |
| 28.05.2021 15:36 | IPO | Director/PDMR Shareholding | RNS |
| 28.05.2021 10:00 | IPO | Joint venture with China Everbright to launch fund | Reach |
| 27.05.2021 07:00 | IPO | Portfolio co Pulmocide completes $92m Series C | Reach |
| 26.05.2021 14:44 | IPO | Update on AGM | RNS |
| 20.05.2021 10:01 | IPO | Scrip Dividend Reference Price | RNS |
| 17.05.2021 12:44 | IPO | Additional fair value gain of £20m | RNS |
| 12.05.2021 12:08 | IPO | Holding(s) in Company | RNS |
| 10.05.2021 11:15 | IPO | Investor webinars | Reach |
| 06.05.2021 18:13 | IPO | Notice of AGM, Annual Report, Scrip Dividend | RNS |
| 06.05.2021 17:55 | IPO | LTIP & DBSP awards; Director/PDMR shareholding | RNS |
| 05.05.2021 07:00 | IPO | Portfolio company Inivata acquired by NeoGenomics | RNS |
| 05.05.2021 07:00 | IPO | Portfolio company Kuur acquired by Athenex | RNS |
| 04.05.2021 07:00 | IPO | Portfolio company Oxford Nanopore raises £195m | RNS |
| 07.04.2021 11:27 | IPO | Director/PDMR Shareholding | RNS |
| 31.03.2021 09:15 | IPO, XSG | Holding(s) in Company | RNS |
| 30.03.2021 07:05 | IPO | Oxford Nanopore announces preparing for IPO in H2 | RNS |
| 26.03.2021 12:26 | IPO | EMA positive opinion for Diurnal's Chronocort | RNS |
| 10.03.2021 07:00 | IPO | Annual Results | RNS |
| 04.03.2021 18:07 | IPO | Holding(s) in Company | RNS |
| 02.03.2021 12:03 | IPO | Holding(s) in Company | RNS |
| 24.02.2021 10:33 | IPO | Notice of Results | RNS |
| 18.02.2021 16:31 | IPO | Holding(s) in Company | RNS |
| 18.02.2021 08:00 | IPO | Holding(s) in Company | RNS |
| 17.02.2021 07:00 | IPO | Portfolio company ApcinteX acquired by Centessa | Reach |
| 10.02.2021 07:00 | IPO | IP Group, Inc. raises $50.0m (£36.5m*) of funding | Reach |
| 09.02.2021 15:52 | IPO | Holding(s) in Company | RNS |
| 02.02.2021 17:15 | IPO | Holding(s) in Company | RNS |
| 11.01.2021 17:29 | IPO | Holding(s) in Company | RNS |
| 06.01.2021 16:57 | IPO | Portfolio co Hinge Health completes $300m round | RNS |
| 06.01.2021 11:34 | IPO, MIRI | Holding(s) in Company | RNS |
| 06.01.2021 07:00 | IPO | Portfolio co Oxbotica completes £36m funding round | Reach |
